Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HRS 2026: GLP-1 Agonists and AF Risk Beyond Weight Loss
Author(s): Kenneth Bilchick Added: 2 weeks ago
HRS Congress 2026 — Dr Kenneth Bilchick (UVA Heart & Vascular Center, Charlottesville, VA, US) joins us to discuss findings from a study examining whether the protective effect of glucagon-like peptide-1 (GLP-1) receptor agonists on atrial fibrillation risk operates independently of weight loss and survival.Interview Questions:What is the current understanding of how GLP-1 receptor agonists may… View more

Cardiovascular Kidney Metabolic
Is Obesity Management Crucial for Ablation Success?
Author(s): Kyaw Z Win , Matthew J Armstrong , Richard P Steeds , et al Added: 12 months ago

Electrophysiology & Arrhythmia
Job title: Head of the School of Psychology
Prof Jason Halford is Head of the School of Psychology at the University of Leeds, and President of the European Association for the Study of Obesity (EASO). His research has focused on eating behaviour and weight management, and the role of psychological factors in weight gain and weight loss, with a recent focus on stress and coping. View more
Neha Pagidipati
Job title: Assistant Professor of Medicine
Neha J Pagidipati is an Assistant Professor of Medicine and cardiovascular disease prevention specialist. Since 2011, she has conducted research on cardiometabolic disease prevention, lifestyle modification and weight management. She is currently an NIH K12 scholar in Implementation and Dissemination Science. Dr Pagidipati is building the Duke Cardiometabolic Disease Prevention Program, which… View more
Research Area(s) / Expertise: Job title: Director of the Cardiometabolic Program
EAST-AFNET 4: Early Rhythm Control Effective in AF Patients with Obesity and Diabetes
Added: 9 months ago Source:  Radcliffe CVRM
A prespecified secondary analysis of the EAST-AFNET 4 trial has found that the benefits of an early rhythm control strategy for patients with recently diagnosed atrial fibrillation (AF) are maintained regardless of whether patients have obesity or diabetes.¹ These findings suggest that clinicians should not withhold this therapeutic approach based on these common metabolic comorbidities.The… View more

Cardiovascular Kidney Metabolic

Electrophysiology & Arrhythmia
HRS 2026: ICE vs TEE-Guided LAAO: Safety and Effectiveness Data
Author(s): Enrico Ferro Added: 1 week ago
HRS 2026 – Dr Enrico Ferro (Beth Israel Deaconess Medical Center, Boston, MA) joins us to discuss findings from the SURPASS study, a large real-world analysis nested within the NCDR LAAO Registry, comparing intracardiac echocardiography (ICE)- and transesophageal echocardiography (TEE)-guided left atrial appendage occlusion (LAAO) using the Watchman FLX device.As ICE continues to gain traction as… View more

Imaging & Diagnostics

Intervention
VT Ablation in High-Risk Patients: Risk Discussion Framework
Author(s): Francesco Santoro Added: 1 month ago
EHRA Congress 2026 — Dr Francesco Santoro (University of Foggia, Foggia, IT) joins us to explore how electrophysiologists can approach risk assessment and decision-making when considering catheter ablation in high-risk ventricular tachycardia patients — a population where the potential benefits of ablation must be carefully weighed against procedural complexity and patient frailty.Interview… View more

Electrophysiology & Arrhythmia
Dr Reddy & Dr Nair on CHAMPION-AF: Redefining Stroke Prevention
Author(s): Devi Nair , Vivek Reddy Added: 1 month ago
ACC.26 - At ACC.26 in New Orleans, Dr Devi Nair (Arkansas, US) and Dr Vivek Reddy (New York, US) dissect the late-breaking CHAMPION‑AF trial, a large randomized comparison of first-line left atrial appendage closure with WATCHMAN FLX versus continued NOAC therapy in patients with non-valvular AF who can tolerate anticoagulation. They review the trial design, post‑implant antithrombotic and… View more

Prevention & Chronic Conditions

Electrophysiology & Arrhythmia
Job title: Associate Professor of Medicine